GSK Confirms This Isn't the First Time for China Bribery

July 17, 2014

Amidst a year-long bribery scandal investigation in China, GlaxoSmithKline now admits it fired staff in China for bribing officials back in 2001.

The Financial Times reports that U.S. prosecutors, while investigating the current allegations, will take a closer look at the earlier scandal as well, which involved the firing of about 30 China vaccine business employees for bribing Chinese officials and taking kickbacks.

If the U.S. Department of Justice determines that GSK has demonstrated pattern of corrupt behavior, the department could potentially take a tougher stance towards GSK.

Read the Financial Times article